Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis.

被引：0

作者：

Rizzoli, R

Roux, C

Greenspan, S

Bone, H

Schnitzer, T

Watts, N

Adami, S

Uebelhart, B

Peverly, C

Kaur, A

Wu, M

Orloff, J

Santora, A

机构：

[1] Univ Geneva, Hop Cantonal, CH-1211 Geneva, Switzerland

[2] Hop Cochin, F-75674 Paris, France

[3] Univ Pittsburgh, Pittsburgh, PA 15260 USA

[4] Michigan Bone Clin, Detroit, MI USA

[5] Northwestern Univ, Chicago, IL 60611 USA

[6] Emory Univ, Atlanta, GA 30322 USA

[7] Univ Verona, I-37100 Verona, Italy

[8] Merck Res Labs, Rahway, NJ USA

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2001年 / 16卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S527 / S527

页数：1

共 50 条

[1] Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis
Rizzoli, R
Roux, C
Greenspan, S
Bone, H
Schnitzer, T
Watts, N
Adami, S
Uebelhart, B
Foldes, J
Peverly, C
Santora, A
Kaur, A
Wu, M
Orloff, J
JOURNAL OF RHEUMATOLOGY, 2001, 28 : 25 - 25
[2] Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis
Rizzoli, R
Roux, C
Greenspan, S
Bone, H
Schnitzer, T
Watts, N
Adami, S
Foldes, J
Uebelhart, B
Peverly, C
Santora, A
Kaur, A
Wu, M
Orloff, J
BONE, 2001, 28 (05) : S94 - S94
[3] Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis
Greenspan, SL
Bone, G
Schnitzer, TJ
Watts, NB
Adami, S
Foldes, AJ
Roux, C
Levine, MA
Uebelhart, B
Santora, AC
Kaur, A
Peverly, CA
Orloff, JJ
Rizzoli, R
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (11) : 1988 - 1996
[4] Once-weekly alendronate: Two year subgroup efficacy analyses in postmenopausal women with osteoporosis.
Bone, H
Felsenberg, D
Greenwald, M
Schnitzer, T
Kaur, A
Cudny, M
Peverly, C
Orloff, J
Santora, A
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S526 - S526
[5] Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis
Sebba, AI
Bonnick, SL
Kagan, R
Thompson, DE
Skalky, CS
Chen, EL
de Papp, AE
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (12) : 2031 - 2041
[6] Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis
Luckey, M
Kagan, R
Greenspan, S
Bone, H
Kiel, RDP
Simon, J
Sackarowitz, J
Palmisano, J
Chen, E
Petruschke, RA
de Papp, AE
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2004, 11 (04): : 405 - 415
[7] Preference study of alendronate 70 mg once weekly and alendronate 10 mg once daily in postmenopausal women with osteoporosis.
Palmisano, J
Lewiecki, EM
Rosen, C
Bockman, RS
Vanaman, LK
Smith, ME
Wang, L
Yates, J
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S64 - S64
[8] Alendronate 70 mg Once Weekly and alendronate 10 mg Once Daily preference study in postmenopausal women with osteoporosis.
Palmisano, J
Lewiecki, EM
Rosen, C
Bockman, RS
Vanaman, LK
Smith, M
Wang, L
Yates, J
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S404 - S404
[9] Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis
Schnitzer, T
Bone, HG
Crepaldi, G
Adami, S
McClung, M
Kiel, D
Felsenberg, D
Recker, RR
Tonino, RP
Roux, C
Pinchera, A
Foldes, AJ
Greenspan, SL
Levine, MA
Emkey, R
Santora, AC
Kaur, A
Thompson, DE
Yates, J
Orloff, JJ
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2000, 12 (01) : 1 - 12
[10] Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: A randomized double-blind study
Rosen, CJ
Hochberg, MC
Bonnick, SL
McClung, M
Miller, P
Broy, S
Kagan, R
Chen, E
Petruschke, RA
Thompson, DE
de Papp, AE
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (01) : 141 - 151

← 1 2 3 4 5 →